100% found this document useful (1 vote)
306 views21 pages

Strides Arcolab Limited's Dividend Pay-Out Decision - Final2

1) Strides Arcolab Limited has three business divisions and previously relied heavily on revenue from its Agila business, which it has now sold. 2) The company is considering three dividend payout options: zero dividend, 15-20% payout, or residual payout. Zero dividend would allow the company flexibility but could cause agency issues. 3) A 15-20% conservative payout would align with the company's past practices but limits upside. Residual payout signals growth but may not appeal to all shareholders given the company's performance and stage of development.

Uploaded by

Lucas Tai
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
100% found this document useful (1 vote)
306 views21 pages

Strides Arcolab Limited's Dividend Pay-Out Decision - Final2

1) Strides Arcolab Limited has three business divisions and previously relied heavily on revenue from its Agila business, which it has now sold. 2) The company is considering three dividend payout options: zero dividend, 15-20% payout, or residual payout. Zero dividend would allow the company flexibility but could cause agency issues. 3) A 15-20% conservative payout would align with the company's past practices but limits upside. Residual payout signals growth but may not appeal to all shareholders given the company's performance and stage of development.

Uploaded by

Lucas Tai
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
You are on page 1/ 21

Strides Arcolab Limited

’s Dividend Pay-out De
cision
Introduction: Strides

• Three business divisions: Pharmaceuticals, Specialties, biotechnology.(Before sold


Aglia)
• No revenue from biologics business and low revenue from oral protect. ( 201
3)
• Focus on export, forging partnerships and concentrating on building scale-to-sell.
• In the mid-2000s started investing in R&D
• Most of revenue from Aglia.(Before sold Aglia)
Background:

• Pharmaceutical industry worth 34 billion USD in 2013-14


• Agila was acquired by Mylan Inc. for 1.725 billion USD
• Deal was valued at 18.7x Agila’s EBIDTA(cash flow increase)
• Proposed dividend payout of $650-700 million – 5,050 % dividend rate and divide
nd payout ratio of 85%
Sale of Agila (Reason):

• Deal was valued 18.7x EBIDTA


• Deal size more than the market value of Strides and also higher than Mylan’s 1.3
billion dollars revenue from Asia-Pacific region.
• The CEO of the company wanted to focus on Biotech company and legacy busines
s of strides.
• Stride wanted to reduce its leverage and use proceeds of sale to resolve its debts.
• Comparable deals:
 Novartis acquired Ebewe Pharma $1.2 B, 4.7 times sales
 Mylan acquired Bioniche Pharma, $550 M, 4.2 times revenue
 Abbott Laboratories acquired Piramal Healthcare- $3.72 B, 8.7 times sales
Three dividend options

(1) Zero dividend pay-out:

(2) 15-20 percent dividend pay-out

(3) Residual dividend pay-out


First option: zero dividend pay-out
The reason why zero dividend pay-out should be done

 Non-conducive equity markets made funding more difficult

 International credit rating agencies, S&P and Fitch, downgrading India sovereign

ratings to a negative in 2012

 Tightening monetary policy in 2013 to prevent rupee from depreciating

 These make company hard to raise funds, in this payout decision Strides can hold

certain amount of capital in case of future increasing financing cost


The opportunity for Strides

 Huge opportunities that the biologics space posed

Global Biologics Sale: 2013 – 2018 (In $ Billion)


2013 2018
Patented sales 124 116
Global
Off parent US 4 31
Biologics Sale Off patent European 15 43
Union/Other
Influence of zero dividend pay-out

Pros Cons
 If new business will success, stock
 Agency problems
price will appreciate
 Payout ratio will change
 More flexible to use their earnings
History of zero dividend pay-out

 In the past, Strides had did three times zero dividend pay-out, we can see that Stride’s stock price change
Second option: 15-20 percent dividend p
ay-out
Conservative option: 15-20 percent dividend pay-out

• Conservative policy: consistent with Strides’ past dividend payout

Less than 22
percent over
the past decade

• The goal is to align the dividend policy with the long-term growth of the company rather than with q
uarterly earnings volatility
• The Clientele effect: investors can have a direct impact on the price of a security when a drastic chan
ge in dividend policy that affects their investment objectives
Conservative option: 15-20 percent dividend pay-out

Strides shareholding pattern, 2012


• Advantage Banks,
Finanical
Instutional
For investors: Others Investors,
23% Insurance
 The amount of dividend will still increase as long as earnings increase companies
4% Foreign
 It meets the requirement of institutional investors who Institional
Investors
Mutual Funds 37%
prefer companies with stable dividends 8%
Indian
Promoters
28%

For Strides:
 It will not raise the expectation of investors for high dividend pay-out in the future
 Relative to residual dividend pay-out policy, investors are less skeptical of the future growth of Strides
 It makes it easier for management to decide how much of earnings should be retained
 The firm can hold certain amount of capital in case of future increasing financing cost
Conservative option: 15-20 percent dividend pay-out

• Disadvantage

 The additional cash holdings could cause agency problem

 It cannot be changed without seriously affecting investors’ attitude toward financial sta
nding of the company

 If the company pays stable dividends in spite of its incapacity, it will be suicidal in the lo
ng-run.
Third option: residual dividend pay-out
The Influence of residual dividend pay-out

Pros Cons
• Minimizes new stock issues. • Can only appeal shareholders who

• More flexible for the need of firm do not have a preference whether

has. their returns are in the form of


immediate dividends or long-term
Uncertain capital gain.
• Signals associated with great dividend. • More suitable for firm in early stage.
The trend of ROA

10
ROA trend
6
The use of residual dividend policy: 6 4 4
3 4
2
2 0

-2

-6 -7

-10

➢ The performance of ROA isn’t strong


enough to persuade shareholder to
execute residual dividend policy.
Dividend Pay-out

Announcement
Dividend
Dividend
Pay-out Trend of Strides
Dividend
Effective Date (%) Remarks
Date Type
Rs.500.0000 per
10/12/2013 19/12/2013 Special 5000%
share(5000%)Special Dividend

28/02/2013 30/05/2013 Final 20%


Rs.2.0000 per  Special type of dividend
share(20%)Dividend

27/02/2012 14/05/2012 Final 20% would be a drastic


24/02/2011 18/05/2011 Final 15%
change from Stride’s
24/02/2010 21/05/2010 Final 15%

31/01/2007 12/06/2007 Final 20% AGM


previous pay-out policy.
09/02/2006 06/06/2006 Final 20% AGM

28/03/2005 13/06/2005 Final 15% AGM (Revised)

10/02/2000 Interim 20%

Source:https://economictimes.indiatimes.com/strides-pharma-science-ltd/infocompanydividends/companyid-2118.cms
The use of residual dividend policy


The use
Employee pay-out
of residual dividend
Unit: million policy:
Amount Percentage

→ 1. Employee Stock Option Scheme Employee pay-out 50~55 0.04

2. Employee Stock Purchase Scheme Minority pay-out 100 0.07

• Minority pay-out Transaction cost 275~300 0.21

→ To minority partners in Brazil, Canada and Debt retirement 250 0.18


Australia. Cash dividends 650~700 0.49
• Transaction costs Total 1365 1
→ Tax of deal. The proceeds 1725
• Debt retirement Biotech capital 100 0.07
• Cash dividends
• Capital expenditure
“Stay the course” might be a best policy

• If 15-20 percent dividend pay-out policy is proposed by Kumar:

 The market value of shares tend to be stable since the clientele effect can be avoided

 It might receive less opposition from the Board

 Compared to residual dividend pay-out policy, Strides could invest more money in th
e new biologics market

 Strides could rely on internal financing in the next few years


Ending

Thanks for your attention!

You might also like